2017
DOI: 10.1080/0284186x.2017.1327721
|View full text |Cite
|
Sign up to set email alerts
|

The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
25
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 14 publications
2
25
0
Order By: Relevance
“…The registry has collected data of more than 1000 patients, approximately 50% from published cohort studies, and 50% of unpublished data. 7,8,10,11,[17][18][19] In the registry, 25•3% of patients in a W&W approach developed a local regrowth in the first two years of follow-up. This local regrowth rate is considerably higher than the pooled 2-year local regrowth rate of 15•7% reported in the meta-analyis of Dossa et al This is probably explained by the strict inclusion criteria in the studies of the meta-analysis, whereas the registry is more based on an ' all-comers' strategy without narrow selection criteria.…”
Section: Discussionmentioning
confidence: 99%
“…The registry has collected data of more than 1000 patients, approximately 50% from published cohort studies, and 50% of unpublished data. 7,8,10,11,[17][18][19] In the registry, 25•3% of patients in a W&W approach developed a local regrowth in the first two years of follow-up. This local regrowth rate is considerably higher than the pooled 2-year local regrowth rate of 15•7% reported in the meta-analyis of Dossa et al This is probably explained by the strict inclusion criteria in the studies of the meta-analysis, whereas the registry is more based on an ' all-comers' strategy without narrow selection criteria.…”
Section: Discussionmentioning
confidence: 99%
“…Besides the use of CRT to become eligible for organ preservation in intermediate risk rectal cancer patients, SCRT with delayed surgery has been proposed as alternative to SCRT-IS and was investigated by the Stockholm III trial [14] and by a prospective non-randomized study in elderly patients [34]. The Stockholm III trial showed comparable oncological outcomes between SCRT with delayed surgery and SCRT-IS [14].…”
Section: Discussionmentioning
confidence: 99%
“…Despite more radiation-induced toxicity after SCRT with delayed surgery, significantly less postoperative complications were observed in this group compared with SCRT-IS. Nonetheless, concerns about delaying surgery after SCRT may include the risk of tumor repopulation [34,35]. Furthermore, the effect of SCRT with delayed surgery on QOL remains yet unknown.…”
Section: Discussionmentioning
confidence: 99%
“…No difference in R0 resection, DM, postoperative or late complications could be found but there was an improved OS in patients receiving consolidative chemotherapy. 220…”
Section: Toxicity From Radiotherapymentioning
confidence: 99%